Nicolau syndrome (NS) is a rare injection-related local complication. Some drugs have been implicated to cause this syndrome. Several cases were previously reported in the literature. In this paper, an interesting case of NS in a 30-year-old male patient after intramuscular self-injection of diclofenac was presented.
Nicolau syndrome (NS) is a rare complication arising from an incorrect local injection of various drugs. The injection site is characterized by pain, erythema, plaque, and necrosis. [1] In this article, an NS in a 30-year-old male after self-injection of diclofenac was presented.
During our literature review, we could not identify any NS case due to self-injection of diclofenac. This syndrome is a preventable complication. Its incidence can be reduced by the application of safe injection methods. [2] This case emphasizes an undesired and potentially dangerous consequence of intramuscular self-injection. Thus, we want to stress that self-injection can be a significant risk factor in the occurrence of NS.
A 30-year-old male was admitted with complaints of pain and redness in the right hip. His complaints began 10 days after the self-injection of dicofenac because of back pain. In physical examination, vital signs were stable. An irregular-edged, ecchymotic, irregular, about 8 cm × 6 cm plaque-type skin lesion raising from the skin was identified in the right gluteal region [ Figure 1 ]. There was no history of underlying disease or trauma. Based on the patient's history and clinical presentation, he was diagnosed with NS due to self-injection of diclofenac. Laboratory examinations, imaging, and biopsy could not be performed because of the patient's refusal. Supportive treatment including local wound care, debridement, and pain management was administered to the patient. He was discharged from the emergency room by a recommendation of control at outpatient clinic.
NS, also known as embolia cutis medicamentosa and livedo-like dermatitis, is a rare cutaneous adverse reaction at the site of intramuscular, intraarticular, or rarely subcutaneous injection of particular drugs. [1, 3] NS cases were reported after intramuscular penicillin, [4, 5] Nicolau syndrome caused by the "self-injection" of diclofenac [6] intramuscular diclofenac, [3, 7] intraarticular glucocorticoid, [8] and subcutaneous etanercept. [9] NS presents with serious pain at the injection site followed by the development of bluish skin discoloration. The livedoid discoloration can be recognized with sharp and angulated margins. Sometimes, it presents with a reticulate pattern which can be considered as noninflammatory retiform purpura, livedo-like dermatitis, and livedoid dermatitis with severe necrosis. Skin discoloration may ultimately result in necrosis and ulceration, which can affect subcutaneous deeper tissues and muscles. [1, 10] Although the exact mechanism is unknown, NS was previously attributed to immunologic/allergic mechanisms, injection technique, pH, or other chemical-physical properties of the administered drug. However, experimental studies controverted this hypothesis. [9] Inadvertent paravasal injection, which can lead to vessel damage, acute arterial thrombosis, and subsequent necrosis, is a widely accepted hypothesis in the pathogenesis. This hypothesis was supported by Guarneri et al. in their cases of NS following intramuscular injection of ketorolac tromethamine and thiocolchicoside. [10, 11] Diagnosis is mainly based on clinical presentation. Skin biopsy shows necrotic changes caused by ischemia. Ultrasonography and magnetic resonance imaging may be helpful in determining the extent of the damage. Early start of treatment has been reported to reverse skin necrosis. Treatment should be aimed at improving vascular flow. In severe cases, surgical debridement may be required. Systemic antibiotics have a significant place in the management of this syndrome. [1, 12] Necrotizing fasciitis should take place in the differential diagnosis of NS. Necrotizing fasciitis is caused by hemolytic streptococci or mixed bacteria including anaerobes, which rapidly spreads from subcutaneous tissues to deeper layers. Necrotizing fasciitis usually occurs after surgery or penetrating trauma which is characterized by serious pain and erythema of the affected skin which then shows purplish discoloration and forms vesicles or ulcers. Symptoms are much more excessive than clinical signs. There is usually gas accumulation within tissues which can be detected by plain films. [1, 12] It is necessary to perform a careful injection since NS can result in compartment syndrome, sepsis, lower extremity amputation, and mortality due to acute renal and liver failure. [13, 14] However, it is a preventable complication. Cold compress application should be avoided as it can aggravate tissue necrosis. The Z-track injection should be preferred as it is a safe method of intramuscular injection which prevents or minimizes this syndrome. [1, 2, 12, 14] Financial support and sponsorship Nil.
